• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: April 1-5, 2013

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

April 1-5, 2013
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/2/13Champions Gate, FLDouglas Throckmorton, Karen RileyN/AKeynote Speech at 2013 National Rx Drug Abuse Summit
John M. Taylor, III, J.D., Counselor to the Commissioner4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy4/1/13-4/5/13 N/AN/AN/ANo Significant Meetings
Leona Brenner-Gati, M.D., Acting Deputy Commissioner for Medical Products and Tobacco4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel4/5/13Silver Spring, MDN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine4/5/13via TeleconferenceSteve VaughnRick Hill (US Department of Agriculture); Joanne Wallace (Drug Information Association); Barbara Freishchem (International Animal Health Organization); Kornelia Grein, David MacKay (European Medicines Agency)Upcoming Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Walter Harris, Chief Operating Officer4/1/13- 4/5/13N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition4/2/13College Park, MDPhil Spiller, Michael Roosevelth, Linda Katz, Dan Fabricant, Corey Hilmas, Louisa Nickerson, Nancy YanishJay Siois (Consumer Healthcare Products Association); Peter Reinecke (United Natural Products Alliance); Anthony Young; Micheal McGuffin (American Herbal Producs Association); Dougals Mackay; Rend Al-Mondhiry; Steve Mister (Council for Responsible Nutrition)Draft of Guidance on New Dietary Ingredient (NDI) 
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition4/3/13College Park, MDLinda Tollefson, Don Zink, Nega Beru, Susan Bernard, Sherri Dennis, Suzy Fitzpatrick, Clark Carrington, Nancy YanishSam Cohen (University of Nebresaka Medical Center); Carol Freysinger (Juice Products Association); Gail Charnley (Healthrisk Strategies) Risk Assessment for Inorganic Arsenic 
Peter Lurie, Acting Associate Commissioner for Policy and Planning4/1/13 - 4/5/13N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Michele Mital, Acting Associate Commissioner for Legislation4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Melinda Plaiser, Acting Associate Commissioner for Regulatory Affairs4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/4/13Silver Spring, MD Steve Pollack, Joel MyklebustRobert J. Meyer (Virginia Center for Translational and Regulatory Sciences)Regulatory Science 
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research4/5/13-4/6/13Columbia, MON/AN/ASpeech at the 10th Annual Meeting of the MidSouth Computational Biology and Bioinformatics Society
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine4/2/13-4/3/13Washington, DC N/ASeveral members of leadership in the food, beverage and consumer product scientific community and government and academic expertsGrocery Manufacturer's of America Science Forum
Mary Lou Valdez, Associate Commissioner for International Programs4/5/13Rockville, MDLeslie Ball, Carl Sciacchitano Several representatives from the US Pharmacopeial ConventionJoint Meeting between FDA and the US Pharmacopeial Convention
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs4/1/13-4/5/13N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/1/13Silver Spring, MDLaurie Burke, Billy Dunn, Chuck Cooper, Mark WaltonLynn Hudson (C-Path); Mike Panzara (Sanofi/Genzyme); Gordon Francis (Novartis)First Multiple Sclerosis Outcome Assessments Consortium/FDA Annual Workshop
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/4/13via Video ConferenceN/AJames Shannon (GlaxoSmithKline Research and Development); Robert Califf (Duke University)Scinovations Symposium, Innovations in Clinical Development
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/2/13Philadelphia, PAN/AMary Oates (Pfizer USA); Craig Kennedy (Merck); Ken Shead (Boeing)International Society for Pharmaceutical Engineering Best Innovation and Quallity Practices from Non-Pharma Industries
Mitchell R. Zeller, J.D., Director, Center for Tobacco Products4/2/13Washington, DCKimberly ElliottSeveral Staff and Senator Tom Harkin (D-IA) Tobacco Control Act Update/Briefing 
Mitchell R. Zeller, J.D., Director, Center for Tobacco Products4/2/13Washington, DCKimberly ElliottSeveral Staff and Senator Sherrod Brown (D-OH)Tobacco Control Act Update/Briefing